Skip to main content
Premium Trial:

Request an Annual Quote

James Weyhenmeyer, Barbara Dalton, Barbara Wood, Jane Wasman, Edward Weisberg

Premium
James Weyhenmeyer has been named senior vice president of the State University of New York Research Foundation and senior vice provost for research at SUNY, effective March 3.
 
In this newly created position, Weyhenmeyer will coordinate SUNY’s Empire Innovation Program to recruit research faculty; lead research, development, and technology programs at the foundation; and serve as primary liaison to the university centers and medical campuses.
 
Weyhenmeyer is a professor of cell biology, pathology, and neuroscience at the University of Illinois. He has also served as the interim vice president for technology and economic development, associate vice president for academic affairs, and associate vice president for economic development and corporate relations at UI.
 
Weyhenmeyer has also served as executive director of IllinoisVENTURES. He received his PhD from Indiana University and completed his postdoc at the University of Iowa.
 

 
The New York Biotechnology Association this week announced the appointment of Barbara Dalton, Barbara Wood, and Jane Wasman to its board of directors.
 
Dalton is vice president for venture capital at Pfizer, and leads Pfizer Venture Investments in a broad range of therapeutics.
 
Wood is the senior vice president, general counsel, and secretary at OSI Pharmaceuticals. Prior to this, Wood was a partner in the corporate department of the New York office of Squadron Ellenoff Plesent & Sheinfeld (now Hogan and Hartson).
 
Wasman has been executive vice president, general counsel, and corporate secretary for Acorda Therapeutics since May 2004. Prior to this, she held various positions at Schering-Plough, including staff vice president and associate general counsel.
 

 
UTEK Corporation this week said that it has appointed Edward Weisberg as vice president.
 
Weisberg previously served as vice president of e-Commerce at iBasis, president of BX.com, and senior partner at Paradigm Management Consulting Group. He received a BA from the University of Pennsylvania and an MS in management from the Sloan School of Management atthe Massachusetts Institute of Technology.
 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.